Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An evaluation of pozelimab for the treatment of CHAPLE disease.
Can S, Yorgun Altunbas M, Ozen A. Can S, et al. Among authors: yorgun altunbas m. Expert Opin Biol Ther. 2024 Dec 10. doi: 10.1080/14712598.2024.2438740. Online ahead of print. Expert Opin Biol Ther. 2024. PMID: 39657032 Review.
Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease.
Bayram Catak F, Catak MC, Babayeva R, Toubia J, Warnock NI, Celmeli F, Hafizoglu D, Yakici N, Kayaoglu B, Surucu N, Yalcin Gungoren E, Can S, Yorgun Altunbas M, Karakus IS, Kiykim A, Orhan F, Bilgic Eltan S, Karakoc-Aydiner E, Ozen A, Erman B, Gursel M, Kok CH, Cildir G, Baris S. Bayram Catak F, et al. Among authors: yorgun altunbas m. J Allergy Clin Immunol. 2024 Dec 2:S0091-6749(24)01284-3. doi: 10.1016/j.jaci.2024.11.032. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39631446
Long-term immunological changes after corrective cardiac surgery.
Bilgic-Eltan S, Amirov R, Babayeva R, Yorgun Altunbas M, Karakurt T, Can S, Yalcin Gungoren E, Bozkurt S, Ozturk N, Catak MC, Bulutoglu A, Onder G, Ng YY, Hatırnaz Ng O, Karakoc-Aydiner E, Ozen AO, Baris S. Bilgic-Eltan S, et al. Among authors: yorgun altunbas m. Scand J Immunol. 2024 Dec;100(6):e13418. doi: 10.1111/sji.13418. Epub 2024 Oct 30. Scand J Immunol. 2024. PMID: 39474990
Diverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey.
Bekis Bozkurt H, Bayram Catak F, Sahin A, Yalcin Gungoren E, Gemici Karaarslan B, Yakici N, Yorgun Altunbas M, Catak MC, Can S, Amirov R, Bozkurt S, Ozturk N, Bilgic Eltan S, Kasap N, Bal Cetinkaya F, Orhan F, Arga M, Cavkaytar O, Kiykim A, Karakoc-Aydiner E, Ozen A, Baris S. Bekis Bozkurt H, et al. Among authors: yorgun altunbas m. J Clin Immunol. 2024 Sep 16;45(1):9. doi: 10.1007/s10875-024-01791-w. J Clin Immunol. 2024. PMID: 39283523
Insights into Patient Experiences with Facilitated Subcutaneous Immunoglobulin Therapy in Primary Immune Deficiency: A Prospective Observational Cohort.
Yalcin Gungoren E, Yorgun Altunbas M, Dikici U, Meric Z, Eser Simsek I, Kiykim A, Can S, Karabiber E, Yakici N, Orhan F, Cokugras H, Aydogan M, Ozdemir O, Bilgic Eltan S, Baris S, Ozen A, Karakoc-Aydiner E. Yalcin Gungoren E, et al. Among authors: yorgun altunbas m. J Clin Immunol. 2024 Aug 5;44(8):169. doi: 10.1007/s10875-024-01771-0. J Clin Immunol. 2024. PMID: 39098942 Free PMC article.
MHC Class II Deficiency: Clinical, Immunological, and Genetic Insights in a Large Multicenter Cohort.
Gulec Koksal Z, Bilgic Eltan S, Topyildiz E, Sezer A, Keles S, Celebi Celik F, Ozhan Kont A, Gemici Karaaslan B, Sefer AP, Karali Z, Arik E, Ozek Yucel E, Akcal O, Karakurt LT, Yorgun Altunbas M, Yalcin K, Uygun V, Ozek G, Babayeva R, Aydogmus C, Ozcan D, Cavkaytar O, Keskin O, Kilic SS, Kiykim A, Arikoglu T, Genel F, Gulez N, Guner SN, Karaca NE, Reisli I, Kutukculer N, Altintas DU, Ozen A, Karakoc Aydiner E, Baris S. Gulec Koksal Z, et al. Among authors: yorgun altunbas m. J Allergy Clin Immunol Pract. 2024 Sep;12(9):2490-2502.e6. doi: 10.1016/j.jaip.2024.06.046. Epub 2024 Jul 10. J Allergy Clin Immunol Pract. 2024. PMID: 38996837
Rapamycin Controls Lymphoproliferation and Reverses T-Cell Responses in a Patient with a Novel STIM1 Loss-of-Function Deletion.
Karakus IS, Catak MC, Frohne A, Bayram Catak F, Yorgun Altunbas M, Babayeva R, Bal SK, Eltan SB, Yalcin Gungoren E, Esen F, Zemheri IE, Karakoc-Aydiner E, Ozen A, Caki-Kilic S, Kraakman MJ, Boztug K, Baris S. Karakus IS, et al. Among authors: yorgun altunbas m. J Clin Immunol. 2024 Apr 5;44(4):94. doi: 10.1007/s10875-024-01682-0. J Clin Immunol. 2024. PMID: 38578569 Free PMC article.
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study.
Ozen A, Chongsrisawat V, Sefer AP, Kolukisa B, Jalbert JJ, Meagher KA, Brackin T, Feldman HB, Baris S, Karakoc-Aydiner E, Ergelen R, Fuss IJ, Moorman H, Suratannon N, Suphapeetiporn K, Perlee L, Harari OA, Yancopoulos GD, Lenardo MJ; Pozelimab CHAPLE Working Group. Ozen A, et al. Lancet. 2024 Feb 17;403(10427):645-656. doi: 10.1016/S0140-6736(23)02358-9. Epub 2024 Jan 23. Lancet. 2024. PMID: 38278170 Clinical Trial.
Evaluation of Clinical and Immunological Alterations Associated with ICF Syndrome.
Bilgic Eltan S, Nain E, Catak MC, Ezen E, Sefer AP, Karimi N, Kiykim A, Kolukisa B, Baser D, Bulutoglu A, Kasap N, Yorgun Altunbas M, Yalcin Gungoren E, Kendir Demirkol Y, Kutlug S, Hancioglu G, Dilek F, Yildiran A, Ozen A, Karakoc-Aydiner E, Erman B, Baris S. Bilgic Eltan S, et al. Among authors: yorgun altunbas m. J Clin Immunol. 2023 Dec 22;44(1):26. doi: 10.1007/s10875-023-01620-6. J Clin Immunol. 2023. PMID: 38129713
12 results